01 1Fagron Inc
02 1Kalchem International inc
03 1Nantong Jinghua Pharmaceutical Co., Ltd.
04 1Professional Compounding Centers of America dba PCCA
01 2PHENYLBUTAZONE
02 2Phenylbutazone
01 1China
02 1Netherlands
03 1U.S.A
04 1United Kingdom
NDC Package Code : 51552-1562
Start Marketing Date : 2018-03-20
End Marketing Date : 2025-06-16
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 60592-909
Start Marketing Date : 2020-11-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59348-0010
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1011
Start Marketing Date : 2013-06-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
70
PharmaCompass offers a list of Phenylbutazone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Phenylbutazone manufacturer or Phenylbutazone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Phenylbutazone manufacturer or Phenylbutazone supplier.
PharmaCompass also assists you with knowing the Phenylbutazone API Price utilized in the formulation of products. Phenylbutazone API Price is not always fixed or binding as the Phenylbutazone Price is obtained through a variety of data sources. The Phenylbutazone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE, including repackagers and relabelers. The FDA regulates 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE supplier is an individual or a company that provides 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE active pharmaceutical ingredient (API) or 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE finished formulations upon request. The 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE suppliers may include 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE API manufacturers, exporters, distributors and traders.
click here to find a list of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE suppliers with NDC on PharmaCompass.
We have 4 companies offering 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE
Get in contact with the supplier of your choice:
